Skip to main content

AusPAR: Denosumab

Australian Public Assessment Report
Device/Product Name
Prolia
Active ingredients
Denosumab
AusPAR Date
Published
Submission Number
PM-2017-01353-1-5
Submission Type
Major variation; extension of indications
Decision
Approved

Help us improve the Therapeutic Goods Administration site